In a historic first for Dell Children’s Medical Center, UT Health Austin and the University of Texas at Austin, a team of pediatric heart transplant surgeons successfully implanted a donor heart in an 18-year-old patient.
Bastrop County Cares, along with Dell Medical School and community organizations, launches a breast cancer screening program for uninsured women.
Blessing Oyeniyi, M.D., works to increase diversity in health care as a way to improve patient outcomes and as a microcosm of larger social issues.
UT Health Austin and Ascension Seton launch Digestive Health, an innovative multidisciplinary clinical partnership bringing together highly specialized providers into a team-based system of care.
Dell Med’s Institute for Military and Veteran Family Wellness launches the Texas Veterans Network to better serve veterans and their family members transitioning to civilian life.
Katharine McNiel, an Austin native, is a fourth-year student at Dell Medical School with a drive to understand — and care for — those around her.
Dell Med student Will Squiers is exploring the ways teaching and medicine intersect through everything from his dual degree to his community involvement.
Cancer research is getting a boost at Dell Med and UT Austin after several research teams received grants from the Cancer Prevention and Research Institute of Texas (CPRIT).
Dell Med alum Gregory Scott Brown, a trained psychiatrist and self-billed wellness advocate, encourages open conversation and reduced stigma around mental health.
UT Health Austin clinics rapidly adapted their care model to telemedicine at the start of the pandemic, but access may be reduced unless emergency reimbursement changes are made permanent.
In a commentary for the Journal of General Internal Medicine, Dell Med’s Dr. Michael Pignone contends that re-imagining the role of postal employees as health care workers could improve health for millions of Americans.
Dell Med’s Dr. Steven Warach proposes an alternate stroke treatment to protect health care workers from COVID-19 in JAMA Neurology.
Dell Med research featuring Gregory Ippolito shows that convalescent plasma therapy is safe for critically ill COVID-19 patients.